Blog
CellNet™ makes its debut at ISBT 2026 in Kuala Lumpur, with its research published in Vox Sanguinis
Our first international congress for CellNet™: a booth at KLCC, poster P388 on our supercritical CO₂ filter, and the research published in ISBT’s journal.
In brief
- Sangtech debuted CellNet™ at the 39th International Congress of the ISBT, June 20–24, 2026, at the Kuala Lumpur Convention Centre.
- Our poster P388 presented a supercritical CO₂-modified leukoreduction filter with enhanced microparticle removal.
- The abstract is published in Vox Sanguinis, the journal of the International Society of Blood Transfusion.
KUALA LUMPUR, June 26, 2026. This week Sangtech took CellNet™ to its first international congress. At the 39th International Congress of the International Society of Blood Transfusion (ISBT), held June 20–24 at the Kuala Lumpur Convention Centre (KLCC) with the Malaysian Blood Transfusion Society, we ran a booth, presented a poster and met the people who make and use blood components around the world.
A booth at KLCC
At booth O56, visitors could handle CellNet™ filters and see them built into whole blood collection sets. Our team spent the congress in conversation with blood center staff, set manufacturers and researchers about what one filtration step at the whole blood stage can do for the red cells and plasma a donation becomes.
The booth also carried our new Edison Awards Silver, presented in April for the process behind CellNet™.
Poster P388: the research
Our poster, P388, presented “A Novel Supercritical CO₂-Modified Leukoreduction Filter with Enhanced Microparticle Removal”. The study was carried out with National Taiwan University, National Taiwan University Hospital and Taipei Medical University.
Figure 1Sangtech’s two heads of R&D beside poster P388, “A Novel Supercritical CO₂-Modified Leukoreduction Filter with Enhanced Microparticle Removal”.
The study looked at supercritical CO₂-assisted impregnation as a sustainable, solvent-free way to modify the polymer nonwovens inside a leukocyte filter, and evaluated a prototype filter for leukocyte removal, red cell recovery and microparticle reduction across storage conditions and blood products.
- Leukocytes: residual leukocytes below 1 × 10⁶ per unit, with high red cell recovery and practical filtration times, for both whole blood and pre-storage packed red cells.
- Microparticles: storage microparticles reduced by 70–83% (manufacturer data).
- Safety: extracts of the modified material showed no cytotoxic response, with cell viability above 90%.
Published in Vox Sanguinis
The abstract is published in Vox Sanguinis, the journal of the International Society of Blood Transfusion, in its ISBT 2026 congress abstracts. It puts the science behind CellNet™ on the record for the transfusion medicine community.
With our research partners
The work behind the poster was a collaboration. In Kuala Lumpur, the Sangtech team joined Professor Thierry Burnouf and his colleagues, who worked with us on the study, for dinner to mark the congress and plan what comes next.
Sangtech’s technology, made in Taiwan
CellNet™ is Sangtech’s technology and a trademark of Sangtech Lab Inc. Sangtech developed it and holds the patents on its supercritical CO₂ process in Taiwan, the United States, Korea and Japan. CellNet™ PR is the first and only commercial whole blood inline leukoreduction filter in the world manufactured without organic solvents or process wastewater.
CellNet™ media is made at our ISO 13485 plant in Yilan, Taiwan, and built into CellNet™ PR, an inline whole blood filter supplied as a component to the companies that make blood collection sets. The process uses no organic solvents and produces no process wastewater; the figures are on our sustainability page.
ISBT. ISBT Kuala Lumpur 2026: 39th International Congress of the ISBT, June 20–24, 2026, Kuala Lumpur Convention Centre, with the Malaysian Blood Transfusion Society.
See all sourcesA novel supercritical CO₂ modified leukoreduction filter with enhanced microparticle removal. Abstract, ISBT 2026 congress abstracts, Vox Sanguinis, 2026.
See all sourcesSangtech Lab Inc. Poster P388, “A Novel Supercritical CO₂-Modified Leukoreduction Filter with Enhanced Microparticle Removal”, 39th International Congress of the ISBT, Kuala Lumpur, June 2026 (manufacturer data).
See all sources